fbpx
VideoInterviews

Havn Life Sciences CEO on Decriminalization of Psychedelics in Oregon and Washington D.C.

By Shadd Dales

Havn Life Sciences CEO Tim Moore joined us on The Dales Report to discuss the recent news earlier this week concerning the US Election and the decriminalization of psychedelics in Oregon and Washington D.C. both.

Preliminary results indicated just after 10 p.m. EST on Tuesday evening that Initiative 81 in Washington, D.C. had passed, decriminalizing a wide range of psychedelic drugs and substances. By Wednesday morning, results indicated that 76.5 percent voted ‘yes’.

Across the country in the state of Oregon, Oregonians voted in favor of Measure 109, which allows patients 21-and-over to buy, possess, and consume psychedelic drugs at “psilocybin service centers.”

RELATED: Revive Therapeutics and Havn Life Science Enter Into Psychedelic Partnership Agreement


Shadd Dales

Shadd Dales is the Founder and President of The Dales Report and has an extensive background in the business media industry.

His work translates into over 15 years in mainstream media that included roles with BNN Bloomberg, CTV Properties and the iHeart Radio Network.

Shadd is considered one of the leading on air talents in both the cannabis and psychedelic space and has interviewed some of the most notable CEO names in the industry.

Shadd’s vision is to establish a content platform that is equivalent to a mainstream broadcast produced in a format that is relevant for today’s investor.

You might also like
Cannabis

TDR Cannabis Exclusive With Jon Levine Of MariMed

Cannabis

David Klein On Canopy Growth’s Rightsizing, Earnings Report

Cannabis

MariMed CEO Levine: Earnings Aid Challenging Market

Trends

Awakn’s Ben Sessa Tells All About MDMA and Netflix Docuseries

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More